Analysis of acute rejection caused by immunosuppressants self-withdrawal after liver transplantation in three cases
-
摘要:
目的 探讨肝移植术后患者自行停药致急性排斥反应(AR)的临床特点及治疗。 方法 回顾性分析2004年1月至2013年6月上海交通大学医学院附属瑞金医院肝移植中心收治肝移植术后因自行停药导致AR的3例患者的临床资料。 结果 3例患者均因自行停止服用免疫抑制剂出现肝功能异常而入院治疗,停药18~42 d,经肝穿刺组织病理学结果明确均为急性细胞性排斥反应。给予恢复使用免疫抑制剂的同时采用肾上腺皮质激素(激素)冲击治疗或兔抗人胸腺细胞免疫球蛋白治疗后改小剂量激素维持。2例患者经治疗后好转,另1例经抢救后无效死亡。 结论 肝移植术后自行停药易发生AR,后果严重,应加强对患者的宣传教育,提高其服药依从性。一旦发生AR,即给予恢复使用免疫抑制剂,同时采用激素冲击或抗体治疗。 Abstract:Objective To investigate the clinical features and treatment in patients with acute rejection (AR) caused by immunosuppressants self-withdrawal (IS) after liver transplantation(LT). Methods Clinical data of 3 cases with AR due to IS after LT from January 2004 to June 2013 in Liver Transplantation Center of Ruijin Hospital Affiliated to Medical College of Shanghai Jiaotong University were analyzed retrospectively. Results Three patients were hospitalized for abnormal liver function after IS. The time of IS was 18-42 d. And acute cellular rejection was confirmed by liver biopsy histopathology. Immunosuppressants were reused and small dose of hormone was used after therapy of adrenocortical hormone shock or rabbit anti-human thymocyte immunoglobulin. Two patients recovered after treatment, and 1 patient died after invalid rescue. Conclusions IS after liver transplantation is prone to AR, usually resulting in serious consequences. Publicity and education of patients should be strengthened to improve their compliance of taking medicine. Once AR occurs, immunosuppressive drugs should be reused immediately with hormone shock or antibody therapy simultaneously. -
Key words:
- Liver transplantation /
- Acute rejection /
- Immunosuppressant /
- Immune tolerance
-
表 1 3例肝移植术后因自行停药导致AR患者的临床资料
Table 1. Clinical data of 3 patients with AR caused by immunosuppressants self-withdrawal after liver transplantation
序号 性别 年龄
(岁)自行停药
时间(d)发病距肝移
植时间(年)肝功能Child-
Pugh评分(分)丙氨酸转氨酶(U/L) 总胆红素(μmol/L) 肝穿刺病理结果 入院免疫抑制治疗方案 抗排斥策略 转归 入院时 治疗后 入院时 治疗后 例1 男 56 18 4 8 156 35 172 17 中度AR FK506+MMF 激素冲击 治愈,肝功能恢复正常 例2 女 67 42 3 11 243 178 386 412 重度AR,可见肝细胞坏死 FK506+MMF 激素冲击 死亡 例3 男 43 23 5 9 221 24 258 38 重度AR 初用FK506+MMF后换西罗莫司+小剂量FK506+MMF 即复宁治疗后改
小剂量激素维持肝功能恢复近正常,病理提示慢性排斥反应 -
[1] Liu XQ, Hu ZQ, Pei YF, et al. Clinical operational tolerance in liver transplantation: state-of-the-art perspective and future prospects[J]. Hepatobiliary Pancreat Dis Int,2013,12(1):12-33. doi: 10.1016/S1499-3872(13)60002-8 [2] Ashton-Chess J, Giral M, Brouard S, et al. Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation[J]. Transplantation,2007,84(10):1215-1219. doi: 10.1097/01.tp.0000290683.54937.1b [3] Orlando G, Hematti P, Stratta RJ, et al. Clinical operational tolerance after renal transplantation: current status and future challenges[J]. Ann Surg,2010,252(6):915-928. doi: 10.1097/SLA.0b013e3181f3efb0 [4] Trotter JF, O'Grady J. Operational tolerance after liver transplantation: raising the bar or tripping up?[J]. Am J Transplant,2010,10(10):2193-2194. doi: 10.1111/ajt.2010.10.issue-10 [5] Orlando G, Soker S, Wood K. Operational tolerance after liver transplantation[J]. J Hepatol,2009,50(6):1247-1257. doi: 10.1016/j.jhep.2009.03.006 [6] Wu SL, Pan CE. Tolerance and chimerism and allogeneic bone marrow/stem cell transplantation in liver transplantation[J]. World J Gastroenterol,2013,19(36):5981-5987. doi: 10.3748/wjg.v19.i36.5981 [7] Alexander SI, Smith N, Hu M, et al. Chimerism and tolerance in a recipient of a deceased-donor liver transplant[J]. N Engl J Med,2008,358(4):369-374. doi: 10.1056/NEJMoa0707255 [8] Liu H, Bakthavatsalam R, Meng Z, et al. PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice[J]. Transplant Proc,2013,45(5):1853-1855. doi: 10.1016/j.transproceed.2013.03.015 [9] Schulz-Juergensen S, Marischen L, Wesch D, et al. Markers of operational immune tolerance after pediatric liver transplantation in patients under immunosuppression[J]. Pediatr Transplant,2013,17(4):348-354. doi: 10.1111/petr.2013.17.issue-4 [10] Ezzelarab M, Thomson AW. Tolerogenic dendritic cells and their role in transplantation[J]. Semin Immunol,2011,23(4):252-263. doi: 10.1016/j.smim.2011.06.007 [11] Li L, Wozniak LJ, Rodder S, et al. A common peripheral blood gene set for diagnosis of operational tolerance in pediatric and adult liver transplantation[J]. Am J Transplant,2012,12(5):1218-1228. doi: 10.1111/j.1600-6143.2011.03928.x [12] Bohne F, Martínez-Llordella M, Lozano JJ, et al. Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation[J]. J Clin Invest,2012,122(1):368-382. doi: 10.1172/JCI59411 [13] Shin M, Song S, Moon HH, et al. Characteristics of recipients who achieved spontaneous operational tolerance in adult liver transplantation[J]. Transplant Proc,2013,45(8):3024-3027. doi: 10.1016/j.transproceed.2013.08.015 [14] Talisetti A, Hurwitz M, Sarwal M, et al. Analysis of clinical variables associated with tolerance in pediatric liver transplant recipients[J]. Pediatr Transplant,2010,14(8):976-979. doi: 10.1111/petr.2010.14.issue-8 [15] Ohe H, Waki K, Yoshitomi M, et al. Factors affecting operational tolerance after pediatric living-donor liver transplantation: impact of early post-transplant events and HLA match[J]. Transpl Int,2012,25(1):97-106. doi: 10.1111/tri.2011.25.issue-1 [16] Sánchez-Fueyo A. Hot-topic debate on tolerance: immunosuppression withdrawal[J]. Liver Transpl,2011,17(Suppl 3):S69-S73. http://cn.bing.com/academic/profile?id=1997897305&encoded=0&v=paper_preview&mkt=zh-cn [17] Banff Working Group on Liver Allograft Pathology. Importance of liver biopsy findings in immunosuppression management: biopsy monitoring and working criteria for patients with operational tolerance[J]. Liver Transpl,2012,18(10):1154-1170. doi: 10.1002/lt.v18.10
计量
- 文章访问数: 286
- HTML全文浏览量: 208
- PDF下载量: 11
- 被引次数: 0